According to the latest report by IMARC Group, titled “Nicotine Gum Market Report by Type (2 Mg Nicotine Gum, 4 Mg Nicotine Gum, 6 Mg Nicotine Gum), Application (Withdrawal Clinics, Medical Practice, Individual Smokers, and Others), Distribution Channel (Retail Pharmacies, Specialty Stores, Online Stores, and Others), and Region 2025-2033,” the global nicotine gum market size reached USD 1.7 Billion in 2024. Nicotine gum is a type of chewing gum infused with nicotine, designed to aid those attempting to quit smoking. It works as a nicotine replacement therapy (NRT), which helps alleviate withdrawal symptoms associated with smoking cessation. It contains nicotine, which is released upon chewing and absorbed through the oral mucosa, delivering a controlled amount of nicotine to the body. It aids in reducing cravings for nicotine, irritability, anxiety, and restlessness and helps smokers focus on the behavioral and psychological aspects of quitting smoking. It also assists individuals to quit other forms of tobacco use, such as cigars and chewing tobacco.
Global Nicotine Gum Market Trends:
The increasing awareness about the health risks associated with smoking is encouraging more individuals to quit tobacco products. This represents one of the key factors positively influencing the market. Additionally, doctors, dentists, and other healthcare professionals are increasingly recommending nicotine gum to patients trying to quit smoking. Apart from this, the aging global population with higher tobacco usage rates is also influencing the overall sales of smoking cessation aids like nicotine gum. Moreover, the burgeoning e-commerce sector is making its availability more accessible and consequently attracting a wider consumer base. Looking forward, the market value is projected to reach USD 2.5 Billion by 2033, expanding at a CAGR of 4% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Type, Application, Distribution Channel, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer and Takeda Pharmaceutical Company |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800